Skip to main content

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.

Publication ,  Journal Article
Launonen, I-M; Lyytikäinen, N; Casado, J; Anttila, EA; Szabó, A; Haltia, U-M; Jacobson, CA; Lin, JR; Maliga, Z; Howitt, BE; Strickland, KC ...
Published in: Nat Commun
February 11, 2022

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

February 11, 2022

Volume

13

Issue

1

Start / End Page

835

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Proteomics
  • Prognosis
  • Ovarian Neoplasms
  • Mutation
  • Humans
  • Homologous Recombination
  • Genotype
  • Genes, BRCA2
  • Genes, BRCA1
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Launonen, I.-M., Lyytikäinen, N., Casado, J., Anttila, E. A., Szabó, A., Haltia, U.-M., … Färkkilä, A. (2022). Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun, 13(1), 835. https://doi.org/10.1038/s41467-022-28389-3
Launonen, I. -. M., N. Lyytikäinen, J. Casado, E. A. Anttila, A. Szabó, U. -. M. Haltia, C. A. Jacobson, et al. “Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.Nat Commun 13, no. 1 (February 11, 2022): 835. https://doi.org/10.1038/s41467-022-28389-3.
Launonen I-M, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia U-M, et al. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 Feb 11;13(1):835.
Launonen, I. .. M., et al. “Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.Nat Commun, vol. 13, no. 1, Feb. 2022, p. 835. Pubmed, doi:10.1038/s41467-022-28389-3.
Launonen I-M, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia U-M, Jacobson CA, Lin JR, Maliga Z, Howitt BE, Strickland KC, Santagata S, Elias K, D’Andrea AD, Konstantinopoulos PA, Sorger PK, Färkkilä A. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 Feb 11;13(1):835.

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

February 11, 2022

Volume

13

Issue

1

Start / End Page

835

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Proteomics
  • Prognosis
  • Ovarian Neoplasms
  • Mutation
  • Humans
  • Homologous Recombination
  • Genotype
  • Genes, BRCA2
  • Genes, BRCA1